{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:12:39Z","timestamp":1791198759063,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.canlet.2014.12.016","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T01:00:11Z","timestamp":1422406811000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma"],"prefix":"10.1016","volume":"360","author":[{"given":"Manuela","family":"Hugle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fulda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.12.016_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.4-1-34","article-title":"Rhabdomyosarcoma: an overview","volume":"4","author":"Dagher","year":"1999","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2014.12.016_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pbc.24118","article-title":"Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies","volume":"59","author":"Malempati","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2014.12.016_bib0020","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1158\/0008-5472.CAN-06-1344","article-title":"Phosphoprotein pathway mapping: Akt\/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival","volume":"67","author":"Petricoin","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2014.12.016_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.12.016_bib0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2014.12.016_bib0040","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.12.016_bib0045","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/cncr.23038","article-title":"Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients","volume":"110","author":"Armistead","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2014.12.016_bib0050","first-page":"61","article-title":"Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes","volume":"24","author":"Pazzaglia","year":"2009","journal-title":"Histol. Histopathol"},{"key":"10.1016\/j.canlet.2014.12.016_bib0055","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/sj.onc.1203607","article-title":"Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3\/FKHR","volume":"19","author":"Margue","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.12.016_bib0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2014.12.016_bib0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1158\/1078-0432.CCR-09-0816","article-title":"NVP-BEZ235 as a new therapeutic option for sarcomas","volume":"16","author":"Manara","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2013.05.010","article-title":"Synthetic lethal interaction between PI3K\/Akt\/mTOR and Ras\/MEK\/ERK pathway inhibition in rhabdomyosarcoma","volume":"337","author":"Guenther","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2014.12.016_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: a double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0080","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-10-2451","article-title":"Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway","volume":"17","author":"Naumann","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0085","doi-asserted-by":"crossref","first-page":"35287","DOI":"10.1074\/jbc.M113.495986","article-title":"Pan-Mammalian Target of Rapamycin (mTOR) inhibitor AZD8055 primes rhabdomyosarcoma cells for ABT-737-induced apoptosis by down-regulating Mcl-1 protein","volume":"288","author":"Preuss","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.12.016_bib0090","first-page":"3823","article-title":"The CD95 (APO-1\/Fas) system mediates drug-induced apoptosis in neuroblastoma cells","volume":"57","author":"Fulda","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0095","series-title":"Synergism and Antagonism in Chemotherapy","first-page":"61","article-title":"The median-effect principle and the combination index for quantitation of synergism and antagonism","author":"Chou","year":"1991"},{"key":"10.1016\/j.canlet.2014.12.016_bib0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2014.12.016_bib0105","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10495-007-0129-x","article-title":"Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine","volume":"12","author":"Malik","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2014.12.016_bib0110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","article-title":"Redox regulation of cell survival","volume":"10","author":"Trachootham","year":"2008","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.canlet.2014.12.016_bib0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","article-title":"The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress","volume":"2","author":"Kerksick","year":"2005","journal-title":"J. Int. Soc. Sports Nutr"},{"key":"10.1016\/j.canlet.2014.12.016_bib0120","first-page":"513","article-title":"Vitamin E analogue Trolox C. E.s.r. and pulse-radiolysis studies of free-radical reactions","volume":"255","author":"Davies","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2014.12.016_bib0125","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1038\/onc.2008.310","article-title":"Lysosomal membrane permeabilization in cell death","volume":"27","author":"Boya","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.12.016_bib0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/CAD.0b013e32835a36db","article-title":"Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K\/mTOR inhibitor PI103 by lysosome-mediated apoptosis","volume":"24","author":"Enzenmuller","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2014.12.016_bib0135","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/ijc.27935","article-title":"The dual PI3K\/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial-lysosomal cross-talk","volume":"132","author":"Seitz","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2014.12.016_bib0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2014.12.016_bib0145","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/sj.emboj.7601126","article-title":"Bcl-2 changes conformation to inhibit Bax oligomerization","volume":"25","author":"Dlugosz","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2014.12.016_bib0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.cdd.4400597","article-title":"Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells","volume":"7","author":"Murphy","year":"2000","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2014.12.016_bib0155","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1158\/0008-5472.CAN-13-0940","article-title":"Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance","volume":"73","author":"Dai","year":"2013","journal-title":"Cancer Res"},{"issue":"2012","key":"10.1016\/j.canlet.2014.12.016_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cdd.2011.96","article-title":"Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death","volume":"19","author":"Galluzzi","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2014.12.016_bib0165","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/emboj.2010.112","article-title":"Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest","volume":"29","author":"Harley","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2014.12.016_bib0170","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1038\/cddis.2013.360","article-title":"Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death","volume":"4","author":"Eichhorn","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canlet.2014.12.016_bib0175","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/MCB.00882-09","article-title":"Cyclin-dependent kinase 1-mediated Bcl-xL\/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis","volume":"30","author":"Terrano","year":"2010","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2014.12.016_bib0180","doi-asserted-by":"crossref","first-page":"35517","DOI":"10.1074\/jbc.M805019200","article-title":"Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance","volume":"283","author":"Upreti","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.12.016_bib0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1073\/pnas.2533920100","article-title":"Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions","volume":"101","author":"Deng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2014.12.016_bib0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2014.12.016_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18632\/oncotarget.242","article-title":"Mcl-1 ubiquitination and destruction","volume":"2","author":"Inuzuka","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2014.12.016_bib0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature09732","article-title":"SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction","volume":"471","author":"Inuzuka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2014.12.016_bib0205","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2014.12.016_bib0210","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/MCB.00620-06","article-title":"Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization","volume":"27","author":"Ding","year":"2007","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2014.12.016_bib0215","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4161\/auto.25573","article-title":"A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy","volume":"9","author":"Wang","year":"2013","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.canlet.2014.12.016_bib0220","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/0008-5472.CAN-12-1365","article-title":"Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism","volume":"73","author":"Rahmani","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0225","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ijc.28206","article-title":"Concurrent inhibition of PI3K and mTORC1\/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma","volume":"133","author":"Muller","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2014.12.016_bib0230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.12.016_bib0235","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","article-title":"Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1","volume":"96","author":"Biggs","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2014.12.016_bib0240","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1158\/0008-5472.CAN-12-3767","article-title":"FOXO3a is a major target of inactivation by PI3K\/AKT signaling in aggressive neuroblastoma","volume":"73","author":"Santo","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0245","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1158\/0008-5472.CAN-10-0176","article-title":"FOXO1A is a target for HER2-overexpressing breast tumors","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.12.016_bib0250","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/onc.2008.24","article-title":"FOXOs, cancer and regulation of apoptosis","volume":"27","author":"Fu","year":"2008","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514007599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514007599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T11:07:20Z","timestamp":1598699240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383514007599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0304383514007599"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.12.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}